Jun Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jun Xiao has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Chuanjie Zhang
Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
40 shared publications - Dan-Feng Xu
Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
40 shared publications - Hai Huang
Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
40 shared publications - Hanqing Liu
Division of Life Sciences and Medicine, Department of Urology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China
40 shared publications - Hongchao He
Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
40 shared publications - Jiawei Ding
Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
40 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
Assessment of pharmacological or toxicological effect of SKLB325 in treating PCa.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
Assessment of pharmacological or toxicological effect of SKLB325 in treating PCa.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
JMJD6/ATF4-sustained enhancer-promoter looping drives the transcription of glutathione biosynthesis pathway.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
JMJD6/ATF4-sustained enhancer-promoter looping drives the transcription of glutathione biosynthesis pathway.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
Identification of SPOP-JMJD6 regulating axis in PCa cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
Identification of SPOP-JMJD6 regulating axis in PCa cells.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
Characterization of JMJD6 clinical relevance in PCa samples.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
Characterization of JMJD6 clinical relevance in PCa samples.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
JMJD6-ATF4 complex regulates the ferroptosis susceptibility in PCa.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
JMJD6-ATF4 complex regulates the ferroptosis susceptibility in PCa.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
JMJD6 is important for SPOP-deficient PCa cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
JMJD6 is important for SPOP-deficient PCa cells.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
Oligonucleotides listed in this study.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
Oligonucleotides listed in this study.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
JMJD6 recruits Med1/14 to sustain enhancers activities.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from JMJD6 Rewires ATF4-Dependent Glutathione Metabolism to Confer Ferroptosis Resistance in SPOP-Mutated Prostate Cancer
JMJD6 recruits Med1/14 to sustain enhancers activities.
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from BBOX1 Is a Metabolic Checkpoint That Mediates Metastatic Cancer Cell Evasion from Immunosurveillance by NK Cells
CXCR2-transduced NK cells display enhanced tumor infiltration.
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from BBOX1 Is a Metabolic Checkpoint That Mediates Metastatic Cancer Cell Evasion from Immunosurveillance by NK Cells
CXCR2-transduced NK cells display enhanced tumor infiltration.
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 5 from BBOX1 Is a Metabolic Checkpoint That Mediates Metastatic Cancer Cell Evasion from Immunosurveillance by NK Cells
Live imaging of coculture of RCC108-derived BBOX1neg cells (white border line) and Lifeact-GFP-expressing NK92 cells with or without slc22a5 knockdown (sislc22a5) when in the presence or absence of carnitine.
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 5 from BBOX1 Is a Metabolic Checkpoint That Mediates Metastatic Cancer Cell Evasion from Immunosurveillance by NK Cells
Live imaging of coculture of RCC108-derived BBOX1neg cells (white border line) and Lifeact-GFP-expressing NK92 cells with or without slc22a5 knockdown (sislc22a5) when in the presence or absence of carnitine.